Does the media favor IRTC or SOLV?

In the previous week, Solventum had 7 more articles in the media than iRhythm Technologies. MarketBeat recorded 10 mentions for Solventum and 3 mentions for iRhythm Technologies. Solventum's average media sentiment score of 1.32 beat iRhythm Technologies' score of 0.62 indicating that Solventum is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment iRhythm Technologies 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Solventum 6 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Which has stronger valuation and earnings, IRTC or SNN?

Smith & Nephew SNATS has higher revenue and earnings than iRhythm Technologies. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio iRhythm Technologies $747.14M 5.22 -$44.55M -$0.86 N/A Smith & Nephew SNATS $6.16B 2.13 $625M N/A N/A

Does the media favor IRTC or SNN?

In the previous week, Smith & Nephew SNATS had 2 more articles in the media than iRhythm Technologies. MarketBeat recorded 5 mentions for Smith & Nephew SNATS and 3 mentions for iRhythm Technologies. Smith & Nephew SNATS's average media sentiment score of 0.76 beat iRhythm Technologies' score of 0.62 indicating that Smith & Nephew SNATS is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment iRhythm Technologies 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Smith & Nephew SNATS 3 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media refer more to PEN or IRTC?

In the previous week, Penumbra had 2 more articles in the media than iRhythm Technologies. MarketBeat recorded 5 mentions for Penumbra and 3 mentions for iRhythm Technologies. iRhythm Technologies' average media sentiment score of 0.62 beat Penumbra's score of 0.00 indicating that iRhythm Technologies is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Penumbra 2 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral iRhythm Technologies 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media refer more to GKOS or IRTC?

In the previous week, Glaukos had 8 more articles in the media than iRhythm Technologies. MarketBeat recorded 11 mentions for Glaukos and 3 mentions for iRhythm Technologies. Glaukos' average media sentiment score of 0.65 beat iRhythm Technologies' score of 0.62 indicating that Glaukos is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Glaukos 5 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive iRhythm Technologies 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Which has preferable earnings & valuation, IRTC or LQDA?

iRhythm Technologies has higher revenue and earnings than Liquidia. iRhythm Technologies is trading at a lower price-to-earnings ratio than Liquidia, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio iRhythm Technologies $747.14M 5.22 -$44.55M -$0.86 N/A Liquidia $158.32M 40.00 -$68.92M $0.14 508.64

Does the media prefer IRTC or LQDA?

In the previous week, Liquidia had 8 more articles in the media than iRhythm Technologies. MarketBeat recorded 11 mentions for Liquidia and 3 mentions for iRhythm Technologies. iRhythm Technologies' average media sentiment score of 0.62 beat Liquidia's score of 0.54 indicating that iRhythm Technologies is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment iRhythm Technologies 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Liquidia 5 Very Positive mention(s) 3 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

iRhythm Technologies (IRTC) Competitors

$118.68 +2.55 (+2.20%)

Closing price 07/13/2026 04:00 PM Eastern

Extended Trading

$118.40 -0.28 (-0.23%)

As of 04:16 AM Eastern

Compare

IRTC vs. SOLV, SNN, PEN, GKOS, and LQDA

Should you buy iRhythm Technologies stock or one of its competitors? MarketBeat compares iRhythm Technologies with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with iRhythm Technologies include Solventum (SOLV), Smith & Nephew SNATS (SNN), Penumbra (PEN), Glaukos (GKOS), and Liquidia (LQDA). These companies are all part of the "medical equipment" industry.

How does iRhythm Technologies compare to Solventum?

iRhythm Technologies (NASDAQ:IRTC) and Solventum (NYSE:SOLV) are both medical companies, but which is the better investment? We will compare the two businesses based on the strength of their media sentiment, profitability, risk, dividends, institutional ownership, earnings, valuation and analyst recommendations.

iRhythm Technologies has a beta of 1.27, suggesting that its stock price is 27% more volatile than the broader market. Comparatively, Solventum has a beta of 0.66, suggesting that its stock price is 34% less volatile than the broader market.

Solventum has a net margin of 17.33% compared to iRhythm Technologies' net margin of -3.53%. Solventum's return on equity of 23.51% beat iRhythm Technologies' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
iRhythm Technologies	-3.53%	-10.26%	-1.39%
Solventum	17.33%	23.51%	7.63%

In the previous week, Solventum had 7 more articles in the media than iRhythm Technologies. MarketBeat recorded 10 mentions for Solventum and 3 mentions for iRhythm Technologies. Solventum's average media sentiment score of 1.32 beat iRhythm Technologies' score of 0.62 indicating that Solventum is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
iRhythm Technologies	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Solventum	6 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

iRhythm Technologies presently has a consensus price target of $187.38, suggesting a potential upside of 57.89%. Solventum has a consensus price target of $83.67, suggesting a potential upside of 7.98%. Given iRhythm Technologies' stronger consensus rating and higher probable upside, research analysts clearly believe iRhythm Technologies is more favorable than Solventum.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
iRhythm Technologies	1 Sell rating(s)	1 Hold rating(s)	12 Buy rating(s)	2 Strong Buy rating(s)	2.94
Solventum	1 Sell rating(s)	6 Hold rating(s)	7 Buy rating(s)	0 Strong Buy rating(s)	2.43

Solventum has higher revenue and earnings than iRhythm Technologies. iRhythm Technologies is trading at a lower price-to-earnings ratio than Solventum, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
iRhythm Technologies	$747.14M	5.22	-$44.55M	-$0.86	N/A
Solventum	$8.33B	1.61	$1.56B	$8.16	9.50

Summary

Solventum beats iRhythm Technologies on 9 of the 15 factors compared between the two stocks.

How does iRhythm Technologies compare to Smith & Nephew SNATS?

iRhythm Technologies (NASDAQ:IRTC) and Smith & Nephew SNATS (NYSE:SNN) are both medical companies, but which is the better investment? We will contrast the two companies based on the strength of their media sentiment, profitability, valuation, institutional ownership, analyst recommendations, earnings, risk and dividends.

iRhythm Technologies currently has a consensus price target of $187.38, suggesting a potential upside of 57.89%. Smith & Nephew SNATS has a consensus price target of $30.93, suggesting a potential downside of 0.49%. Given iRhythm Technologies' stronger consensus rating and higher possible upside, research analysts clearly believe iRhythm Technologies is more favorable than Smith & Nephew SNATS.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
iRhythm Technologies	1 Sell rating(s)	1 Hold rating(s)	12 Buy rating(s)	2 Strong Buy rating(s)	2.94
Smith & Nephew SNATS	0 Sell rating(s)	5 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.17

In the previous week, Smith & Nephew SNATS had 2 more articles in the media than iRhythm Technologies. MarketBeat recorded 5 mentions for Smith & Nephew SNATS and 3 mentions for iRhythm Technologies. Smith & Nephew SNATS's average media sentiment score of 0.76 beat iRhythm Technologies' score of 0.62 indicating that Smith & Nephew SNATS is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
iRhythm Technologies	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Smith & Nephew SNATS	3 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Smith & Nephew SNATS has a net margin of 0.00% compared to iRhythm Technologies' net margin of -3.53%. Smith & Nephew SNATS's return on equity of 0.00% beat iRhythm Technologies' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
iRhythm Technologies	-3.53%	-10.26%	-1.39%
Smith & Nephew SNATS	N/A	N/A	N/A

25.6% of Smith & Nephew SNATS shares are owned by institutional investors. 1.0% of iRhythm Technologies shares are owned by insiders. Comparatively, 1.0% of Smith & Nephew SNATS shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Smith & Nephew SNATS has higher revenue and earnings than iRhythm Technologies.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
iRhythm Technologies	$747.14M	5.22	-$44.55M	-$0.86	N/A
Smith & Nephew SNATS	$6.16B	2.13	$625M	N/A	N/A

iRhythm Technologies has a beta of 1.27, indicating that its share price is 27% more volatile than the broader market. Comparatively, Smith & Nephew SNATS has a beta of 0.56, indicating that its share price is 44% less volatile than the broader market.

Summary

Smith & Nephew SNATS beats iRhythm Technologies on 9 of the 15 factors compared between the two stocks.

How does iRhythm Technologies compare to Penumbra?

Penumbra (NYSE:PEN) and iRhythm Technologies (NASDAQ:IRTC) are both medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their institutional ownership, dividends, analyst recommendations, profitability, risk, media sentiment, earnings and valuation.

Penumbra has higher revenue and earnings than iRhythm Technologies. iRhythm Technologies is trading at a lower price-to-earnings ratio than Penumbra, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Penumbra	$1.45B	8.62	$177.69M	$4.34	73.41
iRhythm Technologies	$747.14M	5.22	-$44.55M	-$0.86	N/A

Penumbra has a net margin of 11.76% compared to iRhythm Technologies' net margin of -3.53%. Penumbra's return on equity of 10.87% beat iRhythm Technologies' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Penumbra	11.76%	10.87%	8.45%
iRhythm Technologies	-3.53%	-10.26%	-1.39%

Penumbra presently has a consensus target price of $360.33, indicating a potential upside of 13.09%. iRhythm Technologies has a consensus target price of $187.38, indicating a potential upside of 57.89%. Given iRhythm Technologies' stronger consensus rating and higher possible upside, analysts plainly believe iRhythm Technologies is more favorable than Penumbra.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Penumbra	1 Sell rating(s)	14 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.11
iRhythm Technologies	1 Sell rating(s)	1 Hold rating(s)	12 Buy rating(s)	2 Strong Buy rating(s)	2.94

88.9% of Penumbra shares are owned by institutional investors. 2.9% of Penumbra shares are owned by insiders. Comparatively, 1.0% of iRhythm Technologies shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Penumbra has a beta of 0.7, meaning that its stock price is 30% less volatile than the broader market. Comparatively, iRhythm Technologies has a beta of 1.27, meaning that its stock price is 27% more volatile than the broader market.

In the previous week, Penumbra had 2 more articles in the media than iRhythm Technologies. MarketBeat recorded 5 mentions for Penumbra and 3 mentions for iRhythm Technologies. iRhythm Technologies' average media sentiment score of 0.62 beat Penumbra's score of 0.00 indicating that iRhythm Technologies is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Penumbra	2 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
iRhythm Technologies	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

Penumbra beats iRhythm Technologies on 11 of the 17 factors compared between the two stocks.

How does iRhythm Technologies compare to Glaukos?

Glaukos (NYSE:GKOS) and iRhythm Technologies (NASDAQ:IRTC) are both mid-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their risk, dividends, profitability, earnings, valuation, institutional ownership, analyst recommendations and media sentiment.

99.0% of Glaukos shares are owned by institutional investors. 5.9% of Glaukos shares are owned by insiders. Comparatively, 1.0% of iRhythm Technologies shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

iRhythm Technologies has a net margin of -3.53% compared to Glaukos' net margin of -34.34%. Glaukos' return on equity of -6.92% beat iRhythm Technologies' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Glaukos	-34.34%	-6.92%	-5.25%
iRhythm Technologies	-3.53%	-10.26%	-1.39%

Glaukos has a beta of 0.75, indicating that its stock price is 25% less volatile than the broader market. Comparatively, iRhythm Technologies has a beta of 1.27, indicating that its stock price is 27% more volatile than the broader market.

In the previous week, Glaukos had 8 more articles in the media than iRhythm Technologies. MarketBeat recorded 11 mentions for Glaukos and 3 mentions for iRhythm Technologies. Glaukos' average media sentiment score of 0.65 beat iRhythm Technologies' score of 0.62 indicating that Glaukos is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Glaukos	5 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
iRhythm Technologies	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

iRhythm Technologies has higher revenue and earnings than Glaukos. iRhythm Technologies is trading at a lower price-to-earnings ratio than Glaukos, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Glaukos	$551.35M	16.27	-$187.69M	-$3.28	N/A
iRhythm Technologies	$747.14M	5.22	-$44.55M	-$0.86	N/A

Glaukos currently has a consensus price target of $151.77, indicating a potential downside of 0.65%. iRhythm Technologies has a consensus price target of $187.38, indicating a potential upside of 57.89%. Given iRhythm Technologies' stronger consensus rating and higher probable upside, analysts clearly believe iRhythm Technologies is more favorable than Glaukos.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Glaukos	1 Sell rating(s)	1 Hold rating(s)	13 Buy rating(s)	0 Strong Buy rating(s)	2.80
iRhythm Technologies	1 Sell rating(s)	1 Hold rating(s)	12 Buy rating(s)	2 Strong Buy rating(s)	2.94

Summary

iRhythm Technologies beats Glaukos on 9 of the 17 factors compared between the two stocks.

How does iRhythm Technologies compare to Liquidia?

iRhythm Technologies (NASDAQ:IRTC) and Liquidia (NASDAQ:LQDA) are both mid-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their profitability, media sentiment, valuation, earnings, institutional ownership, analyst recommendations, risk and dividends.

Liquidia has a net margin of 7.74% compared to iRhythm Technologies' net margin of -3.53%. Liquidia's return on equity of 46.82% beat iRhythm Technologies' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
iRhythm Technologies	-3.53%	-10.26%	-1.39%
Liquidia	7.74%	46.82%	7.06%

iRhythm Technologies presently has a consensus price target of $187.38, suggesting a potential upside of 57.89%. Liquidia has a consensus price target of $68.88, suggesting a potential downside of 3.28%. Given iRhythm Technologies' stronger consensus rating and higher probable upside, research analysts plainly believe iRhythm Technologies is more favorable than Liquidia.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
iRhythm Technologies	1 Sell rating(s)	1 Hold rating(s)	12 Buy rating(s)	2 Strong Buy rating(s)	2.94
Liquidia	2 Sell rating(s)	1 Hold rating(s)	5 Buy rating(s)	3 Strong Buy rating(s)	2.82

64.5% of Liquidia shares are owned by institutional investors. 1.0% of iRhythm Technologies shares are owned by insiders. Comparatively, 25.6% of Liquidia shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

iRhythm Technologies has a beta of 1.27, suggesting that its stock price is 27% more volatile than the broader market. Comparatively, Liquidia has a beta of 0.55, suggesting that its stock price is 45% less volatile than the broader market.

In the previous week, Liquidia had 8 more articles in the media than iRhythm Technologies. MarketBeat recorded 11 mentions for Liquidia and 3 mentions for iRhythm Technologies. iRhythm Technologies' average media sentiment score of 0.62 beat Liquidia's score of 0.54 indicating that iRhythm Technologies is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
iRhythm Technologies	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Liquidia	5 Very Positive mention(s)	3 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

iRhythm Technologies has higher revenue and earnings than Liquidia. iRhythm Technologies is trading at a lower price-to-earnings ratio than Liquidia, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
iRhythm Technologies	$747.14M	5.22	-$44.55M	-$0.86	N/A
Liquidia	$158.32M	40.00	-$68.92M	$0.14	508.64

Summary

Liquidia beats iRhythm Technologies on 10 of the 17 factors compared between the two stocks.

Get iRhythm Technologies News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding IRTC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

IRTC vs. The Competition

Export

Metric	iRhythm Technologies	MEDICAL INFO SYS Industry	Medical Sector	NASDAQ Exchange
Market Cap	$3.82B	$1.81B	$7.05B	$12.61B
Dividend Yield	N/A	N/A	2.68%	8.00%
P/E Ratio	-138.00	77.24	27.11	24.26
Price / Sales	5.22	7.33	589.14	117.88
Price / Cash	N/A	27.39	29.22	49.36
Price / Book	25.04	5.62	10.75	6.29
Net Income	-$44.55M	-$54.76M	$3.58B	$330.66M
7 Day Performance	-5.12%	-2.15%	-2.10%	-1.35%
1 Month Performance	4.43%	5.30%	3.29%	-0.64%
1 Year Performance	-14.56%	0.86%	26.32%	19.08%

iRhythm Technologies Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
IRTC iRhythm Technologies	3.7984 of 5 stars	$118.68 +2.2%	$187.38 +57.9%	-12.7%	$3.82B	$747.14M	N/A	2,400
SOLV Solventum	3.9393 of 5 stars	$76.72 +1.0%	$83.50 +8.8%	+5.1%	$13.15B	$8.33B	9.40	20,000	News Coverage Analyst Forecast
SNN Smith & Nephew SNATS	2.0246 of 5 stars	$30.69 +0.9%	$30.93 +0.8%	+2.6%	$12.92B	$6.16B	N/A	16,988	News Coverage
PEN Penumbra	1.6224 of 5 stars	$317.87 0.0%	$360.33 +13.4%	+34.2%	$12.51B	$1.45B	73.24	4,700
GKOS Glaukos	1.6838 of 5 stars	$152.74 -1.5%	$151.62 -0.7%	+47.3%	$9.11B	$551.35M	N/A	1,094	Analyst Forecast Insider Trade

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:IRTC) was last updated on 7/14/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

iRhythm Technologies (IRTC) Competitors

IRTC vs. SOLV, SNN, PEN, GKOS, and LQDA

How does iRhythm Technologies compare to Solventum?

Summary

How does iRhythm Technologies compare to Smith & Nephew SNATS?

Summary

How does iRhythm Technologies compare to Penumbra?

Summary

How does iRhythm Technologies compare to Glaukos?

Summary

How does iRhythm Technologies compare to Liquidia?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

IRTC vs. The Competition

iRhythm Technologies Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

iRhythm Technologies (IRTC) Competitors

IRTC vs. SOLV, SNN, PEN, GKOS, and LQDA

How does iRhythm Technologies compare to Solventum?

Which has more volatility & risk, IRTC or SOLV?

Is IRTC or SOLV more profitable?

Does the media favor IRTC or SOLV?

Do analysts rate IRTC or SOLV?

Which has stronger earnings and valuation, IRTC or SOLV?

Summary

How does iRhythm Technologies compare to Smith & Nephew SNATS?

Do analysts rate IRTC or SNN?

Does the media favor IRTC or SNN?

Is IRTC or SNN more profitable?

Do insiders & institutionals believe in IRTC or SNN?

Which has stronger valuation and earnings, IRTC or SNN?

Which has more risk and volatility, IRTC or SNN?

Summary

How does iRhythm Technologies compare to Penumbra?

Which has stronger valuation & earnings, PEN or IRTC?

Is PEN or IRTC more profitable?

Do analysts prefer PEN or IRTC?

Do insiders & institutionals believe in PEN or IRTC?

Which has more risk & volatility, PEN or IRTC?

Does the media refer more to PEN or IRTC?

Summary

How does iRhythm Technologies compare to Glaukos?

Do insiders and institutionals have more ownership in GKOS or IRTC?

Is GKOS or IRTC more profitable?

Which has more volatility and risk, GKOS or IRTC?

Does the media refer more to GKOS or IRTC?

Which has preferable valuation & earnings, GKOS or IRTC?

Do analysts recommend GKOS or IRTC?

Summary

How does iRhythm Technologies compare to Liquidia?

Is IRTC or LQDA more profitable?

Do analysts prefer IRTC or LQDA?

Do institutionals & insiders hold more shares of IRTC or LQDA?

Which has more volatility and risk, IRTC or LQDA?

Does the media prefer IRTC or LQDA?

Which has preferable earnings & valuation, IRTC or LQDA?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

IRTC vs. The Competition

iRhythm Technologies Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools